Kevin K Thao, MD | |
3500 Hoover Rd, Stevens Point, WI 54481-5600 | |
(715) 346-0222 | |
Not Available |
Full Name | Kevin K Thao |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 14 Years |
Location | 3500 Hoover Rd, Stevens Point, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427340090 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 60360 (Wisconsin) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
La Clinica De Los Campesinos, Inc | 8729996574 | 14 |
News Archive
Bristol-Myers Squibb Company and ZymoGenetics, Inc. announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
The Boston Globe: "Caritas Christi Health Care executives have told union negotiators they will shutter St. Elizabeth's Medical Center in Brighton and Carney Hospital in Dorchester if they can't close a deal for the six-hospital chain to be bought by a New York private equity firm. The warning was made during contract talks last week with the Massachusetts Nurses Association, according to two people who attended the meeting.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
› Verified 2 days ago
Entity Name | La Clinica De Los Campesinos, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790786929 PECOS PAC ID: 8729996574 Enrollment ID: O20040806000058 |
News Archive
Bristol-Myers Squibb Company and ZymoGenetics, Inc. announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
The Boston Globe: "Caritas Christi Health Care executives have told union negotiators they will shutter St. Elizabeth's Medical Center in Brighton and Carney Hospital in Dorchester if they can't close a deal for the six-hospital chain to be bought by a New York private equity firm. The warning was made during contract talks last week with the Massachusetts Nurses Association, according to two people who attended the meeting.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
› Verified 2 days ago
Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Bristol-Myers Squibb Company and ZymoGenetics, Inc. announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
The Boston Globe: "Caritas Christi Health Care executives have told union negotiators they will shutter St. Elizabeth's Medical Center in Brighton and Carney Hospital in Dorchester if they can't close a deal for the six-hospital chain to be bought by a New York private equity firm. The warning was made during contract talks last week with the Massachusetts Nurses Association, according to two people who attended the meeting.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Kevin K Thao, MD 3500 Hoover Rd, Stevens Point, WI 54481-5600 Ph: (715) 346-0222 | Kevin K Thao, MD 3500 Hoover Rd, Stevens Point, WI 54481-5600 Ph: (715) 346-0222 |
News Archive
Bristol-Myers Squibb Company and ZymoGenetics, Inc. announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.
The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.
The Boston Globe: "Caritas Christi Health Care executives have told union negotiators they will shutter St. Elizabeth's Medical Center in Brighton and Carney Hospital in Dorchester if they can't close a deal for the six-hospital chain to be bought by a New York private equity firm. The warning was made during contract talks last week with the Massachusetts Nurses Association, according to two people who attended the meeting.
MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.
› Verified 2 days ago
Dr. Kevin Richard Whitney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4100 State Highway 66, Stevens Point, WI 54482 Phone: 715-343-7700 | |
Orlando M Francisco, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 Stanley St, Stevens Point, WI 54481 Phone: 715-341-7332 | |
Dr. Sumeet Kumar Goel, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4100 State Highway 66, Stevens Point, WI 54482 Phone: 715-343-7700 | |
Carol D Rave, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 824 Illinois Avenue, Stevens Point, WI 54481 Phone: 715-342-7500 | |
Oscar G Padilla, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Vern Holmes Dr, Stevens Point, WI 54482 Phone: 715-344-1600 | |
Mariam M Ibdaiwi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4100 State Highway 66, Stevens Point, WI 54482 Phone: 715-997-6016 |